Assyro AI

Orange Book product · Brand (NDA)

XIIDRA

LIFITEGRAST

Brand (NDA)NDA 208073RX BAUSCH AND LOMB INC

At a glance

Jul 11, 2016

Approved

Brand (NDA)

Application

Not listed

TE code

10

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 11, 2016

    10 yr 1 mo ago

  2. Patent 8084047 expires

    Listed drug substance patent expiration.

    May 17, 2026

    1 mo ago

  3. Patent 8592450 expires

    Listed method-of-use patent (U-1880) expiration.

    May 17, 2026

    1 mo ago

  4. Today

  5. Patent 8367701 expires

    Listed drug product patent expiration.

    Apr 15, 2029

    in 2 yr 10 mo

  6. Patent 9447077 expires

    Listed method-of-use patent (U-1900) expiration.

    Apr 15, 2029

    in 2 yr 10 mo

  7. Patent 8168655 expires

    Listed method-of-use patent (U-1880) expiration.

    May 09, 2029

    in 2 yr 11 mo

  8. Patent 9353088 expires

    Listed drug product patent expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  9. Patent 9890141 expires

    Listed drug substance patent expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  10. Patent 8927574 expires

    Listed drug product patent expiration.

    Nov 12, 2030

    in 4 yr 6 mo

  11. Patent 9085553 expires

    Listed drug product patent expiration.

    Jul 25, 2033

    in 7 yr 2 mo

  12. Patent 11058677 expires

    Listed drug product patent expiration.

    Dec 18, 2033

    in 7 yr 7 mo

Pharmaceutical detail

Active ingredient

LIFITEGRAST

Strength

5%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 208073

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8084047May 17, 20261 mo ago
SubstanceProduct
8592450May 17, 20261 mo ago
U-1880
8367701Apr 15, 2029in 2 yr 10 mo
ProductU-1880
9447077Apr 15, 2029in 2 yr 10 mo
U-1900
8168655May 09, 2029in 2 yr 11 mo
U-1880
9353088Oct 21, 2030in 4 yr 5 mo
Product
9890141Oct 21, 2030in 4 yr 5 mo
Substance
8927574Nov 12, 2030in 4 yr 6 mo
Product
9085553Jul 25, 2033in 7 yr 2 mo
Product
11058677Dec 18, 2033in 7 yr 7 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.